Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study

BACKGROUND: Microvascular invasion (MVI) is considered to be one of the important prognostic factors that affect postoperative recurrence in patients with hepatocellular carcinoma (HCC) with variable results across their treatment options. This study was carried out to investigate efficacy of postop...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Liming, Wang, Weihu, Rong, Weiqi, Li, Zhuo, Wu, Fan, Liu, Yunhe, Zheng, Yiling, Zhang, Kai, Siqin, Tana, Liu, Mei, Chen, Bo, Wu, Jianxiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329435/
https://www.ncbi.nlm.nih.gov/pubmed/32611327
http://dx.doi.org/10.1186/s12885-020-07087-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329435/
https://www.ncbi.nlm.nih.gov/pubmed/32611327
http://dx.doi.org/10.1186/s12885-020-07087-7

Ejemplares similares